Brucella suis S2, Brucella melitensis Rev. 1 and Brucella abortus S19 living vaccines: residual virulence and immunity induced against three Brucella species challenge strains in mice-Reference-Cited by-同舟云学术

Brucella suis S2, Brucella melitensis Rev. 1 and Brucella abortus S19 living vaccines: residual virulence and immunity induced against three Brucella species challenge strains in mice

Published:1990-10 Issue:5 Volume:8 Page:462-468
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Bosseray Nicole,Plommet M.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference36 articles.

1. Orally administrable brucellosis vaccine: Brucella suis strain 2 vaccine;Xin;Vaccine,1986

2. Le contrôle des vaccins antibrucelliques par dénombrement des Brucella dans la rate de souris, vaccinées ou non, inoculées par voie intrapéritonéale;Plommet;J. Biol. Stand.,1977

3. Propositions pour une méthode générale de contrôle d'activité des vaccins antibrucelliques;Plommet;Dev. Biol. Stand.,1984

4. Theoretical, practical and statistical basis for a general control method of activity for antibrucella vaccines;Bosseray;Dev. Biol. Stand.,1984

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The development of a human Brucella mucosal vaccine: What should be considered?;Life Sciences;2024-10

2. Contrasting roles for IgM and B-cell MHCII expression in Brucella abortus S19 vaccine-mediated efficacy against B. melitensis infection;mSphere;2024-03-26

3. A novel Galleria mellonella experimental model for zoonotic pathogen Brucella;Virulence;2023-10-23

4. The advances of the Chinese Brucella suis strain 2 vaccine;Animal Research and One Health;2023-07-03

5. Activation of mucosal immunity as a novel therapeutic strategy for combating brucellosis;Frontiers in Microbiology;2022-12-22